Elder Pharma – Strong Dose of Results

Elder Pharma reported 32% YoY growth in top line in Q4FY08 on the back of strong performance of its leading brands. For full year FY08, total revenue increased by 22% YoY to Rs 5481.4 mn. The growth in revenues was mainly on account of strong performance by its leading brands like Shelcal, Chymoral, Eldervit etc.

Elder’s EBDITA margin remained stable at 20.2% during the fourth quarter ended March 2008. For full year FY08, EBDITA margin grew by 280 basis points to 20.2% as compared to 17.4% for last year.

Elder recorded 36.5% YoY growth at net profit level to Rs 204.2 mn during Q4FY08 compared to corresponding quarter last year. For FY08, net profit witnessed growth of 36.1% YoY to Rs 718 mn.

SBI – Tug of War between Analysts

Research Analysts at Citigroup and Morgan Stanley are having a tug of war when it comes to Index Heavyweight State Bank of India. Morgan Stanley Downgraded the bank to Underweight [If you follow their MCSI, then you have to SELL the stock] while, Citigroup lowered the price target but still retained a BUY on the stock.

SBI reported a 21% sequential increase in NPLs. This was driven by higher agricultural NPLs (farmers stopped coming to branches to repay, after the debt waiver scheme announced by government – according to management). The other driver for higher NPLs is SME/ SSI – a sector witnessing some stress. Given that these remain focus areas for growth, we expect an NPL increase as we move forward. Moreover, with NPL coverage of 42%, credit costs could rise significantly. (more…)

Morgan Stanley Overweight on Amtek Auto

Morgan Stanley in a report continues to be OVERWEIGHT on Amtek Auto.

F3Q08 numbers in line with estimates. Consolidated revenues came in at Rs13.2bn, 1.6% above our Rs13.0bn estimate while EBITDA came in at Rs2.3bn, 12.2% below our Rs2.6bn estimate. This excludes one-time Rs297.1m profit on sale of shares booked by Amtek Siccardi (one of the subsidiaries) in F3Q08. Adjusted EBITDA margin came in at 17.2%, 270 bps below 19.9% estimate and 280 bps below last year’s 20%, primarily driven by higher raw material costs. (more…)

GMR – Sabiha Gokcen International Airport

GMR Infrastructure has announced that Istanbul’s Sabiha Gokcen International Airport Investment Development and Operations – the company formed by the consortium of GMR Infrastructure (40%), Limak Holdings (40%) and Malaysia Airports Holdings Berhad (20%), which bid for and won the 20-year operation rights of Sabiha Gokcen International Airport, has started its operations and investments for the construction and management of a 10 million capacity terminal.

The consortium has 20-year operation rights of Sabiha Gokcen International Airport.

Omaxe embraces Spa + Massage Business

Real Estate major, Omaxe Ltd has entered into MOU for establishing and operating SPA and massage knowledge centre, SPA and massage techniques and but not limited to other related services under the name of Thai Privilege Spa in New Delhi and Northern India.

The company has enterd into Spa Franchise agreement for establishing and operating of SPA outlet of Thai Privilege Spa in Noida, India and with Thai Privilege Consultant, a central group of Thailand which is a group of international repute.

Adlabs Films + Lotus Five Star Cinemas Deal

Reliance ADAG’s Adlabs Films has entered into agreement for acquisition of majority and controlling interest in Lotus Five Star Cinemas and will be operating a 51 screen cinema exhibition chain in Malaysia.

The chain will have a footprint across the Malaysia and will be playing mainstream Hollywood films in addition to movies in the Indian languages viz. Hindi, Tamil, Chinese and Malay.

Adlabs currently has 160 screens operating in India. Its international presence, in addition to Malaysia, comprises 220 screens covering the East, Mid West and West Coast of USA as also Mauritius and Nepal.